These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. Samuel RM; Majd H; Richter MN; Ghazizadeh Z; Zekavat SM; Navickas A; Ramirez JT; Asgharian H; Simoneau CR; Bonser LR; Koh KD; Garcia-Knight M; Tassetto M; Sunshine S; Farahvashi S; Kalantari A; Liu W; Andino R; Zhao H; Natarajan P; Erle DJ; Ott M; Goodarzi H; Fattahi F Cell Stem Cell; 2020 Dec; 27(6):876-889.e12. PubMed ID: 33232663 [TBL] [Abstract][Full Text] [Related]
45. Pulmonary surfactant itself must be a strong defender against SARS-CoV-2. Takano H Med Hypotheses; 2020 Nov; 144():110020. PubMed ID: 32590326 [TBL] [Abstract][Full Text] [Related]
46. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? Scagnolari C; Bitossi C; Viscido A; Frasca F; Oliveto G; Scordio M; Petrarca L; Mancino E; Nenna R; Riva E; De Vito C; Midulla F; Antonelli G; Pierangeli A Cytokine; 2021 Apr; 140():155430. PubMed ID: 33508651 [TBL] [Abstract][Full Text] [Related]
47. Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2. Youk J; Kim T; Evans KV; Jeong YI; Hur Y; Hong SP; Kim JH; Yi K; Kim SY; Na KJ; Bleazard T; Kim HM; Fellows M; Mahbubani KT; Saeb-Parsy K; Kim SY; Kim YT; Koh GY; Choi BS; Ju YS; Lee JH Cell Stem Cell; 2020 Dec; 27(6):905-919.e10. PubMed ID: 33142113 [TBL] [Abstract][Full Text] [Related]
48. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19. Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184 [TBL] [Abstract][Full Text] [Related]
49. [Role of ACE2 in COVID-19]. Imai Y Nihon Yakurigaku Zasshi; 2022; 157(2):115-118. PubMed ID: 35228442 [TBL] [Abstract][Full Text] [Related]
50. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Onabajo OO; Banday AR; Stanifer ML; Yan W; Obajemu A; Santer DM; Florez-Vargas O; Piontkivska H; Vargas JM; Ring TJ; Kee C; Doldan P; Tyrrell DL; Mendoza JL; Boulant S; Prokunina-Olsson L Nat Genet; 2020 Dec; 52(12):1283-1293. PubMed ID: 33077916 [TBL] [Abstract][Full Text] [Related]
51. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19. Sturrock A; Zimmerman E; Helms M; Liou TG; Paine R Physiol Rep; 2021 May; 9(9):e14854. PubMed ID: 33991451 [TBL] [Abstract][Full Text] [Related]
52. Long Term Culture of Human Kidney Proximal Tubule Epithelial Cells Maintains Lineage Functions and Serves as an Ex vivo Model for Coronavirus Associated Kidney Injury. Xia S; Wu M; Chen S; Zhang T; Ye L; Liu J; Li H Virol Sin; 2020 Jun; 35(3):311-320. PubMed ID: 32602046 [TBL] [Abstract][Full Text] [Related]
53. Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2. Garcia-Del-Barco D; Risco-Acevedo D; Berlanga-Acosta J; Martos-Benítez FD; Guillén-Nieto G Front Immunol; 2021; 12():655528. PubMed ID: 33841439 [TBL] [Abstract][Full Text] [Related]
54. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models. Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239 [TBL] [Abstract][Full Text] [Related]
55. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients. Lichtensteiger C; Koblischke M; Berner F; Jochum AK; Sinnberg T; Balciunaite B; Purde MT; Walter V; Abdou MT; Hofmeister K; Kohler P; Vernazza P; Albrich WC; Kahlert CR; Zoufaly A; Traugott MT; Kern L; Pietsch U; Kleger GR; Filipovic M; Kneilling M; Cozzio A; Pop O; Bomze D; Bergthaler A; Hasan Ali O; Aberle J; Flatz L J Autoimmun; 2023 Nov; 140():103118. PubMed ID: 37826919 [TBL] [Abstract][Full Text] [Related]
57. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus. Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113 [TBL] [Abstract][Full Text] [Related]
58. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice. Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A mBio; 2021 Apr; 12(2):. PubMed ID: 33879586 [TBL] [Abstract][Full Text] [Related]
59. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice. Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L Front Immunol; 2022; 13():893792. PubMed ID: 35812400 [TBL] [Abstract][Full Text] [Related]
60. SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage. Sui Y; Li J; Venzon DJ; Berzofsky JA Front Immunol; 2021; 12():658428. PubMed ID: 34149696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]